| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1953186 | Biochimie | 2006 | 7 Pages |
Abstract
Conclusion. - At least a part of the autoimmune reaction to aggrecan, displayed by the systemic disease sera, involves the G2 domain. The significant difference observed between these sera and those from other diseases, especially cancer, may suggest a possible discriminatory role of anti-aggrecan antibodies. This may help in the differential diagnosis in complicated clinical cases. However, for this to be confirmed, studies in larger cohorts of patients should be performed.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
D.H. Vynios, I. Tsagaraki, G.H.A. Grigoreas, M. Samiotaki, G. Panayotou, D. Kyriakopoulou, P. Georgiou, D. Korbakis, A. Panayotou, K. Nanouri, M. Assouti, A.P. Andonopoulos,